Precision Therapeutics

Precision Therapeutics

Precision Therapeutics (now Helomics) markets diagnostic assays that help oncologists recommend chemotherapy regimens tailored to patients’ specific tumor genetics.
Precision Dermatology

Precision Dermatology

Precision Dermatology was a specialty pharmaceutical company that sold both prescription and non-prescription skin care products. The company was acquired by Valeant Pharmaceuticals in 2014.
Civitas Therapeutics

Civitas Therapeutics

Civitas was a biopharmaceutical company developing CVT-301, a potentially transformative therapy for people with Parkinson’s disease. Civitas was acquired by Acorda Therapeutics in 2014.
Cadence Pharmaceuticals

Cadence Pharmaceuticals

Cadence was a specialty pharmaceutical company that developed and marketed Ofirmev, an intravenous form of acetaminophen for pain management. Cadence was acquired by Mallinckrodt in 2014.
Amarin Corporation

Amarin Corporation

Amarin is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health.